What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Immune system
Immunology, Immunotherapy, Internal medicine, Cancer and Immune system are his primary areas of study.
His study in Immunology is interdisciplinary in nature, drawing from both Cancer cell and Receptor.
A large part of his Immunotherapy studies is devoted to Immune checkpoint.
He regularly ties together related areas like Oncology in his Internal medicine studies.
His work deals with themes such as Clinical trial, Bioinformatics, Young adult, Gastroenterology and Hepatitis, which intersect with Cancer.
Aurélien Marabelle has included themes like Immunosuppression, Monoclonal antibody and Antigen in his Immune system study.
His most cited work include:
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review (964 citations)
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1. (569 citations)
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1. (569 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Oncology, Immunotherapy, Immune system and Cancer.
Many of his research projects under Internal medicine are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His Oncology research is multidisciplinary, incorporating elements of Proportional hazards model, Disease, Neuroblastoma and Cohort.
His study explores the link between Immunotherapy and topics such as Pharmacology that cross with problems in Agonist.
His Immune system study necessitates a more in-depth grasp of Immunology.
His work carried out in the field of Immunology brings together such families of science as Cancer cell and Blockade.
He most often published in these fields:
- Internal medicine (50.15%)
- Oncology (39.65%)
- Immunotherapy (40.52%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (50.15%)
- Oncology (39.65%)
- Cancer (36.15%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Oncology, Cancer, Immunotherapy and Immune system.
His work in the fields of Pembrolizumab and Adverse effect overlaps with other areas such as In patient.
In the field of Oncology, his study on Renal cell carcinoma overlaps with subjects such as Head and neck squamous-cell carcinoma.
The study incorporates disciplines such as Pseudoprogression, Clinical trial, Disease and Coronavirus disease 2019 in addition to Cancer.
His Immunotherapy research is multidisciplinary, incorporating perspectives in Targeted therapy and Medical physics.
Immunology covers Aurélien Marabelle research in Immune system.
Between 2019 and 2021, his most popular works were:
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. (325 citations)
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. (182 citations)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Immune system
Aurélien Marabelle mainly focuses on Internal medicine, Oncology, Immune system, Cancer and Immunotherapy.
His Internal medicine study integrates concerns from other disciplines, such as Imaging biomarker and Melanoma, Cutaneous melanoma.
His Oncology research integrates issues from Immune checkpoint, Clinical trial, Immunosenescence, CTLA-4 and Tumor antigen.
His Immune system study also includes fields such as
- Patient risk, Virus and Therapeutic effect most often made with reference to Severe acute respiratory syndrome coronavirus 2,
- Coronavirus disease 2019 together with Immunology, Pneumonia, Anti-IL-6, Tocilizumab and Respiratory failure.
His DNA mismatch repair study in the realm of Cancer interacts with subjects such as Microsatellite instability.
His research investigates the connection between Immunotherapy and topics such as Cancer research that intersect with issues in Treatment options, Monoclonal antibody and Antitumor activity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
